Ergawealth Advisors, Inc. Abbott Laboratories Transaction History
Ergawealth Advisors, Inc.
- $184 Billion
- Q2 2024
A detailed history of Ergawealth Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Ergawealth Advisors, Inc. holds 4,223 shares of ABT stock, worth $452,958. This represents 0.24% of its overall portfolio holdings.
Number of Shares
4,223
Previous 6,269
32.64%
Holding current value
$452,958
Previous $713 Million
38.41%
% of portfolio
0.24%
Previous 0.39%
Shares
5 transactions
Others Institutions Holding ABT
# of Institutions
3,113Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.19M-
Vanguard Group Inc Valley Forge, PA165MShares$17.7 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$14.3 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$9.01 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$8.02 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.53 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $188B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...